LNA Sante SA (LNA) AI Stock Analysis

• Market Cap: €260.50M
• Dividend Yield: 2.39%
• Average Volume (3M): 1.83K
• Price to Earnings (P/E): 11.7
• Beta (1Y): 0.53
• Revenue Growth: 9.58%
• EPS Growth: -6.69%
• Country: FR
• Employees: 9,000
• Sector: Healthcare
• Sector Strength: 55
• Industry: Medical - Care Facilities
• EPS (TTM): 0.92
• Shares Outstanding: 10,709,416
• 10 Day Avg. Volume: 1,446
• 30 Day Avg. Volume: 1,826
• PEG Ratio: 7.28
• Price to Book (P/B): 1.06
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 3.41
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €33.00
• Price Target Upside: 32.00% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 74 Outperform
• Price Target: €28.00 ▲(12.00%Upside)

LNA Sante SA's overall score reflects strong financial performance, particularly in cash flow generation, and positive technical indicators. The valuation is favorable with a low P/E ratio and solid dividend yield. The lack of recent earnings call data and corporate events did not impact the score.

LNA Sante SA Business Overview & Revenue Model

Company Description

LNA Santé SA engages in the management and operation of health establishments. The company operates retirement homes, medical and rehabilitation care, home hospital, mental health clinic, and health center. LNA Santé SA was founded in 1990 and is based in Vertou, France.

How the Company Makes Money

LNA Sante SA generates revenue primarily through the operation of nursing homes and rehabilitation centers. The company earns income by providing residential care services to the elderly and those requiring rehabilitation, typically with payment coming from either private individuals, insurance reimbursements, or public health funding. Key revenue streams include accommodation fees, care services, and ancillary services such as catering and additional personal care. The company's earnings are further bolstered by strategic partnerships with healthcare providers and government contracts, which help to ensure a steady flow of residents and patients in their facilities.

LNA Sante SA Financial Statement Overview

Summary

LNA Sante SA shows consistent revenue growth and stable operational margins. The high leverage on the balance sheet presents some risk, but strong cash flow generation supports financial flexibility.

Income Statement

LNA Sante SA has shown consistent revenue growth over the years, with a notable increase from 2023 to 2024. The gross profit margin has weakened compared to previous years, which could indicate rising costs or pricing pressures. However, the EBIT and EBITDA margins remain stable, suggesting operational efficiency. The net profit margin shows a slight decline, which could be a concern if it continues.

Balance Sheet

The company's debt-to-equity ratio is relatively high, reflecting significant leverage. However, the return on equity has been stable, indicating effective use of shareholder funds. The equity ratio is moderate, suggesting a balanced capital structure. Overall, the balance sheet exhibits some risk due to high debt levels, but equity growth is positive.

Cash Flow

LNA Sante SA has demonstrated strong operating cash flow relative to net income, highlighting efficient cash generation. The free cash flow growth has been positive, supporting future investments or debt reduction. The free cash flow to net income ratio is healthy, indicating good cash availability after capital expenditures.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
806.60M	736.09M	728.22M	689.49M	573.89M
	Gross Profit
91.10M	241.09M	622.42M	577.87M	481.03M
	EBIT
68.97M	62.98M	63.78M	55.81M	37.08M
	EBITDA
144.85M	144.63M	141.82M	131.64M	108.17M
	Net Income Common Stockholders
21.82M	23.41M	25.81M	23.51M	7.81M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
75.06M	77.17M	101.98M	152.12M	121.39M
	Total Assets
1.54B	1.51B	1.51B	1.53B	1.50B
	Total Debt
876.44M	887.67M	911.55M	1.00B	971.50M
	Net Debt
801.39M	810.50M	809.57M	852.85M	850.47M
	Total Liabilities
1.21B	1.20B	1.21B	1.31B	1.30B
	Stockholders Equity
313.81M	299.24M	289.33M	216.09M	188.65M
Cash Flow		Free Cash Flow
71.24M	84.56M	89.86M	65.98M	132.74M
	Operating Cash Flow
82.06M	97.50M	103.20M	79.92M	146.50M
	Investing Cash Flow
-23.93M	-15.69M	-41.99M	-27.65M	-205.94M
	Financing Cash Flow
-60.22M	-106.69M	-110.88M	-21.53M	40.24M

LNA Sante SA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 25.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LNA, the sentiment is Positive. The current price of 25 is above the 20-day moving average (MA) of 24.23, above the 50-day MA of 23.57, and above the 200-day MA of 23.93, indicating a bullish trend. The MACD of 0.28 indicates Negative momentum. The RSI at 65.15 is Neutral, neither overbought nor oversold. The STOCH value of 90.03 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:LNA.

LNA Sante SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LNA	74 Outperform	€260.50M	11.72	7.12%	2.39%	9.58%	-6.69%
Sector *	54 Neutral	$5.34B	3.27	-45.10%	3.30%	16.80%	0.02%
0OPS		€1.58B	―	-0.83%	―	―	―
0NEX		€1.72B	0.02	-22.82%	―	―	―
0R9T		€726.99M	19.81	16.07%	2.59%	―	―
0OD6		€1.24B	―	-6.74%	―	―	―
MAAT	41 Neutral	€84.30M	―		―	44.34%	-27.37%

LNA Sante SA Corporate Events

LNA Santé Achieves 2024 Targets Amidst Healthcare Challenges

LNA Santé reported strong financial results for 2024, meeting its targets despite challenges in the healthcare sector. The company achieved a 6.7% increase in operating sales and a 7.7% rise in net operating profit, while managing its debt effectively. The company plans to continue its growth trajectory in 2025, targeting a 6% increase in operating sales and focusing on strategic acquisitions and facility transformations to meet healthcare demands.